Incidence and determinants of adverse events in individuals with HIV commencing Dolutegravir-based antiretroviral therapy in mainland Tanzania.
Fimbo A, Mwalwisi YH, Mwamwitwa K, Matiko D, Mfinanga E, Lyimo J, Sabasaba A, Missago S, Bukundi E, Gotora G, Respick D, Nkayamba A, Masunga E, Mnkugwe RH, Kunambi PP, Munishi C, Musanhu CC, Minzi OMS, Mlugu EM.
Fimbo A, et al. Among authors: mnkugwe rh.
Sci Rep. 2024 Jan 5;14(1):615. doi: 10.1038/s41598-023-51144-7.
Sci Rep. 2024.
PMID: 38182720
Free PMC article.